PT  - JOURNAL ARTICLE
AU  - Cérbulo-Vázquez, A.
AU  - Zavala-Barrios, B.
AU  - Briones-Garduño, JC
AU  - Guerrero-Avendaño, GML
AU  - Arriaga-Pizano, L.
AU  - Ferat-Osorio, E.
AU  - L.,
AU  - Cabrera-Rivera, G.L.
AU  - Miranda-Cruz, P.
AU  - García de la Rosa, M.T.
AU  - Prieto-Chavez, J.L.
AU  - Rivero-Arredondo, V.
AU  - Madera-Sandoval, R.L.
AU  - Cruz-Cruz, A.
AU  - Salazar-Rios, E.
AU  - Serrano-Molina, D.
AU  - De Lira-Barraza, R. C.
AU  - Villanueva-Compean, A. H.
AU  - Esquivel-Pineda, A.
AU  - Ramirez-Montes de Oca, R.
AU  - Flores-Padilla, G.
AU  - López-Macías, C.
TI  - Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico City
AID  - 10.1101/2020.07.14.20153585
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.14.20153585
4099  - http://medrxiv.org/content/early/2020/07/17/2020.07.14.20153585.short
4100  - http://medrxiv.org/content/early/2020/07/17/2020.07.14.20153585.full
AB  - On January 30th, 2020, the WHO declared the outbreak of COVID19, a disease due to the new coronavirus called SARS-CoV-2. Certain comorbidities, symptoms and signs are characteristic of COVID19 in the general population and in pregnant women. However, pregnant women are considered as a high-risk group for COVID19. To know about the frequency of comorbidities, signs and symptoms, the presence of lymphopenia, antibodies response to SARS-CoV2 and cytokine and chemokine serum concentration, six pregnant women with COVID19 were studied at the moment of admission. The lower concentration of CCL17 was detected in the Pregnant COVID19 group, similar concentration of IL-6 was also detected in non-pregnant and pregnant COVID19 patients. Our result show that pregnant and non-pregnant women with COVID19 has similar cytokine profile.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialWe performed an observational, cross-sectional and descriptive study, however, the clinical trial ID is under process.Funding StatementThis project was supported by the Mexican National Research Council (CONACYT), Project No. 313494 (awarded to CLM).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Committee for Scientific Research of the Mexican Social Security Institute reviewed and approved our study. Registration is R-2020-785-095.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article.